Page last updated: 2024-09-05

mk 0852 and Myocardial Infarction

mk 0852 has been researched along with Myocardial Infarction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rossi, G1
Bogaty, P; Kingma, JG; Plante, S1

Other Studies

2 other study(ies) available for mk 0852 and Myocardial Infarction

ArticleYear
[Superaspirin in the platelet aggregation inhibitor therapy].
    Recenti progressi in medicina, 1997, Volume: 88, Issue:12

    Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Integrins; Myocardial Infarction; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Recurrence; Sulfoxides; Thiazolidines; Time Factors; Tyrosine

1997
Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion.
    Journal of the American College of Cardiology, 2000, Volume: 36, Issue:7

    Topics: Animals; Coronary Circulation; Disease Models, Animal; Dogs; Female; Flow Cytometry; Heart; Hemodynamics; Hyperemia; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines

2000